Tabradol
- Product NDC
- 43093-101
- 11-digit product format
- 430930101
- Labeler code
- 43093
- Product ID
- 43093-101_28c7b9e3-07ca-6f9b-e054-00144ff88e88
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine Hydrochloride
- Dosage form
- KIT
- Route
- ORAL
- Labeler
- Fusion Pharmaceuticals LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2009-09-17
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43093-101-01 | Tabradol | 1 in 1 KIT | KIT | 1 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43093-101 | TABRADOL (CYCLOBENZAPRINE HYDROCHLORIDE) KIT [FUSION PHARMACEUTICALS LLC] | 9 | Legacy NDC, 1 package rows | 20160108_5d19ef8b-eef3-4d52-95f5-929765ca6dc7.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 43093-101-01 | 43093010101 | 1 in 1 KIT | Historical |